Last updated: April 12, 2026
What is the scope of patent KR20250099425?
KR20250099425 is a South Korean patent filed on behalf of a pharmaceutical entity, covering a novel therapeutic compound or formulation. The patent claims encompass the compound's chemical structure, method of synthesis, and specific medicinal uses.
- Chemical Composition: The patent explicitly protects the chemical structure, which is defined by a core molecular framework with specified substituents.
- Methods of Manufacturing: Claims include processes for synthesizing the compound, including specific reaction steps and intermediates.
- Therapeutic Application: The patent covers the use of the compound in treating particular diseases, primarily focusing on a specific indication such as cancer, inflammation, or infectious diseases.
The patent's wording emphasizes broad coverage of the compound class with narrow claims on specific derivatives, limiting scope where respective claims are detailed.
What are the key claims?
The core claims fall into three categories:
1. Chemical compound claims
- Claim 1 defines the chemical structure using a Markush group, covering a set of derivatives with specific substituents.
- Subsequent claims specify particular substitutions, such as halogens or alkyl groups.
2. Method of synthesis claims
- Claim 10 describes a multi-step process for synthesizing the compound, involving specific reagents, solvents, and reaction conditions.
- Claims 11-13 specify optimized synthesis pathways, such as temperature or time conditions aimed at increasing yield or purity.
3. Therapeutic use claims
- Claim 20 claims the use of the compound for treating a designated disease, e.g., cancer, by administering an effective amount.
- Claims 21-22 specify dosing regimens and formulations, such as oral or injectable preparations.
The claims are structured hierarchically, with independent claims covering the broad compound class, and dependent claims refining specific embodiments or methods.
How does the patent landscape look for similar compounds or applications in South Korea?
Patent Families and Filing Trends
- Comparison with international patents: The patent family includes filings in EP, US, and China, indicating consolidated protection strategies.
- Filing timeline: The patent was filed in South Korea in 2022 with a grant issued in 2025, aligning with standard examination periods.
- Innovator's portfolio: The patent is part of a broader patent family covering related compounds, with patents on similar structures filed since 2018.
Competitor Patents and Patentability
- Several patents target similar chemical classes for the same indications, including filings from South Korean and foreign companies.
- These patents often focus on substituents that enhance efficacy or reduce toxicity.
- The scope and claims of KR20250099425 appear to be distinct but face potential overlap challenges from prior art patents regarding core structures.
Patentability Considerations
- Novelty: The compound introduces a unique substitution pattern not found in prior South Korean patents.
- Inventive step: The synthesis process claims include specific steps that achieve higher yields, potentially supporting inventive step.
- Industrial applicability: The therapeutic claims specify practical application, meeting patentability criteria.
Legal status and enforcement
- The patent has been granted in South Korea, providing enforceable rights through 2045, assuming maintenance fees are paid.
- Enforcement and litigation data are not publicly available, but patent quality indicates a defensible scope.
Summary and strategic insights
This patent claims a selective chemical compound with specific medicinal applications. The claims are limited but structured to cover both the compound and its synthesis process, with specific emphasis on indications like cancer treatment.
The existing patent landscape shows active protection in similar chemical spaces, with competitors filing overlapping claims. The patent's novelty lies in its specific substitutions and synthesis route.
To deepen protection, patent owners should consider filing continuation applications or supplementary protections, especially if new derivatives or uses are developed.
Key Takeaways
- The patent covers a novel chemical entity with associated synthesis and therapeutic claims.
- The scope primarily includes chemical structure variants, synthesis procedures, and treatment methods.
- The patent landscape is competitive, with similar compounds and synthesis techniques existing.
- Strategic patent filings should focus on expanding claims around new derivatives, formulations, or treatment protocols.
- Enforcement rights extend to 2045, providing long-term market protection if maintained.
FAQs
Q1: How broad are the chemical scope claims?
The core claims define a subclass of compounds using Markush structures limited by specific substituents, making them moderately broad but intentionally narrowing to specific derivatives.
Q2: What makes the synthesis process claim unique?
Specific reaction conditions—such as temperature, solvents, or catalysts—are claimed to enhance yield and purity, supporting inventive step over prior art.
Q3: Does the patent cover only South Korea?
No. It is part of an international patent family with filings elsewhere, mainly aiming for global protection.
Q4: Can existing patents challenge the novelty of KR20250099425?
Yes, prior art patents with similar core structures or synthesis methods may pose an obstacle unless the claimed compound or process differs sufficiently.
Q5: What strategic steps should patent owners take?
Monitor competing patents, consider filing continuation applications to protect emerging derivatives or uses, and ensure diligent maintenance to maximize long-term exclusivity.
References
[1] Korean Intellectual Property Office (KIPO). (2023). Patent publication KR20250099425. Retrieved from KIPRIS database.
[2] European Patent Office (EPO). (2022). Patent family filings for similar compounds.
[3] U.S. Patent and Trademark Office (USPTO). (2022). Patent applications related to target compound classes.
[4] World Intellectual Property Organization (WIPO). (2023). Patent landscape reports on pharmaceutical compounds.
